Your browser doesn't support javascript.
Subgenomic RNA identification in SARS-CoV-2 genomic sequencing data.
Parker, Matthew D; Lindsey, Benjamin B; Leary, Shay; Gaudieri, Silvana; Chopra, Abha; Wyles, Matthew; Angyal, Adrienn; Green, Luke R; Parsons, Paul; Tucker, Rachel M; Brown, Rebecca; Groves, Danielle; Johnson, Katie; Carrilero, Laura; Heffer, Joe; Partridge, David G; Evans, Cariad; Raza, Mohammad; Keeley, Alexander J; Smith, Nikki; Filipe, Ana Da Silva; Shepherd, James G; Davis, Chris; Bennett, Sahan; Sreenu, Vattipally B; Kohl, Alain; Aranday-Cortes, Elihu; Tong, Lily; Nichols, Jenna; Thomson, Emma C; Wang, Dennis; Mallal, Simon; de Silva, Thushan I.
  • Parker MD; Sheffield Bioinformatics Core, The University of Sheffield, Sheffield S10 2HQ, United Kingdom.
  • Lindsey BB; Sheffield Institute for Translational Neuroscience, The University of Sheffield, Sheffield S10 2HQ, United Kingdom.
  • Leary S; Sheffield Biomedical Research Centre, The University of Sheffield, Sheffield S10 2JF, United Kingdom.
  • Gaudieri S; Sheffield Teaching Hospitals NHS Foundation Trust, Department of Virology/Microbiology, Sheffield S10 2JF, United Kingdom.
  • Chopra A; The Florey Institute for Host-Pathogen Interactions and Department of Infection, Immunity and Cardiovascular Disease, Medical School, University of Sheffield, Sheffield S10 2TN, United Kingdom.
  • Wyles M; Institute for Immunology and Infectious Diseases, Murdoch University, Murdoch WA 6150, Western Australia, Australia.
  • Angyal A; Institute for Immunology and Infectious Diseases, Murdoch University, Murdoch WA 6150, Western Australia, Australia.
  • Green LR; Division of Infectious Diseases, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee 37232, USA.
  • Parsons P; School of Human Sciences, University of Western Australia, Crawley WA 6009, Western Australia, Australia.
  • Tucker RM; Institute for Immunology and Infectious Diseases, Murdoch University, Murdoch WA 6150, Western Australia, Australia.
  • Brown R; Sheffield Institute for Translational Neuroscience, The University of Sheffield, Sheffield S10 2HQ, United Kingdom.
  • Groves D; The Florey Institute for Host-Pathogen Interactions and Department of Infection, Immunity and Cardiovascular Disease, Medical School, University of Sheffield, Sheffield S10 2TN, United Kingdom.
  • Johnson K; The Florey Institute for Host-Pathogen Interactions and Department of Infection, Immunity and Cardiovascular Disease, Medical School, University of Sheffield, Sheffield S10 2TN, United Kingdom.
  • Carrilero L; Department of Animal and Plant Sciences, The University of Sheffield, Sheffield S10 2TN, United Kingdom.
  • Heffer J; Department of Animal and Plant Sciences, The University of Sheffield, Sheffield S10 2TN, United Kingdom.
  • Partridge DG; The Florey Institute for Host-Pathogen Interactions and Department of Infection, Immunity and Cardiovascular Disease, Medical School, University of Sheffield, Sheffield S10 2TN, United Kingdom.
  • Evans C; The Florey Institute for Host-Pathogen Interactions and Department of Infection, Immunity and Cardiovascular Disease, Medical School, University of Sheffield, Sheffield S10 2TN, United Kingdom.
  • Raza M; Sheffield Teaching Hospitals NHS Foundation Trust, Department of Virology/Microbiology, Sheffield S10 2JF, United Kingdom.
  • Keeley AJ; Department of Animal and Plant Sciences, The University of Sheffield, Sheffield S10 2TN, United Kingdom.
  • Smith N; IT Services, The University of Sheffield, Sheffield S10 2FN, United Kingdom.
  • Filipe ADS; Sheffield Teaching Hospitals NHS Foundation Trust, Department of Virology/Microbiology, Sheffield S10 2JF, United Kingdom.
  • Shepherd JG; The Florey Institute for Host-Pathogen Interactions and Department of Infection, Immunity and Cardiovascular Disease, Medical School, University of Sheffield, Sheffield S10 2TN, United Kingdom.
  • Davis C; Sheffield Teaching Hospitals NHS Foundation Trust, Department of Virology/Microbiology, Sheffield S10 2JF, United Kingdom.
  • Bennett S; Sheffield Teaching Hospitals NHS Foundation Trust, Department of Virology/Microbiology, Sheffield S10 2JF, United Kingdom.
  • Sreenu VB; Sheffield Teaching Hospitals NHS Foundation Trust, Department of Virology/Microbiology, Sheffield S10 2JF, United Kingdom.
  • Kohl A; The Florey Institute for Host-Pathogen Interactions and Department of Infection, Immunity and Cardiovascular Disease, Medical School, University of Sheffield, Sheffield S10 2TN, United Kingdom.
  • Aranday-Cortes E; The Florey Institute for Host-Pathogen Interactions and Department of Infection, Immunity and Cardiovascular Disease, Medical School, University of Sheffield, Sheffield S10 2TN, United Kingdom.
  • Tong L; Centre for Virus Research, The University of Glasgow, Glasgow G61 1QH, United Kingdom.
  • Nichols J; Centre for Virus Research, The University of Glasgow, Glasgow G61 1QH, United Kingdom.
  • Thomson EC; Centre for Virus Research, The University of Glasgow, Glasgow G61 1QH, United Kingdom.
  • Wang D; Centre for Virus Research, The University of Glasgow, Glasgow G61 1QH, United Kingdom.
  • Mallal S; Centre for Virus Research, The University of Glasgow, Glasgow G61 1QH, United Kingdom.
  • de Silva TI; Centre for Virus Research, The University of Glasgow, Glasgow G61 1QH, United Kingdom.
Genome Res ; 31(4): 645-658, 2021 04.
Article in English | MEDLINE | ID: covidwho-1135943
ABSTRACT
We have developed periscope, a tool for the detection and quantification of subgenomic RNA (sgRNA) in SARS-CoV-2 genomic sequence data. The translation of the SARS-CoV-2 RNA genome for most open reading frames (ORFs) occurs via RNA intermediates termed "subgenomic RNAs." sgRNAs are produced through discontinuous transcription, which relies on homology between transcription regulatory sequences (TRS-B) upstream of the ORF start codons and that of the TRS-L, which is located in the 5' UTR. TRS-L is immediately preceded by a leader sequence. This leader sequence is therefore found at the 5' end of all sgRNA. We applied periscope to 1155 SARS-CoV-2 genomes from Sheffield, United Kingdom, and validated our findings using orthogonal data sets and in vitro cell systems. By using a simple local alignment to detect reads that contain the leader sequence, we were able to identify and quantify reads arising from canonical and noncanonical sgRNA. We were able to detect all canonical sgRNAs at the expected abundances, with the exception of ORF10. A number of recurrent noncanonical sgRNAs are detected. We show that the results are reproducible using technical replicates and determine the optimum number of reads for sgRNA analysis. In VeroE6 ACE2+/- cell lines, periscope can detect the changes in the kinetics of sgRNA in orthogonal sequencing data sets. Finally, variants found in genomic RNA are transmitted to sgRNAs with high fidelity in most cases. This tool can be applied to all sequenced COVID-19 samples worldwide to provide comprehensive analysis of SARS-CoV-2 sgRNA.
Subject(s)

Full text: Available Collection: International databases Database: MEDLINE Main subject: RNA, Viral / Genome, Viral / Sequence Analysis, RNA / SARS-CoV-2 Type of study: Prognostic study Topics: Variants Limits: Animals / Humans Language: English Journal: Genome Res Journal subject: Molecular Biology / Genetics Year: 2021 Document Type: Article Affiliation country: Gr.268110.120

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: RNA, Viral / Genome, Viral / Sequence Analysis, RNA / SARS-CoV-2 Type of study: Prognostic study Topics: Variants Limits: Animals / Humans Language: English Journal: Genome Res Journal subject: Molecular Biology / Genetics Year: 2021 Document Type: Article Affiliation country: Gr.268110.120